Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    July 2018
  1. KINCAID RP, Lam VL, Chirayil RP, Randall G, et al
    RNA triphosphatase DUSP11 enables exonuclease XRN-mediated restriction of hepatitis C virus.
    Proc Natl Acad Sci U S A. 2018 Jul 23. pii: 1802326115.
    PubMed     Text format     Abstract available


  2. KE R, Li H, Wang S, Ding W, et al
    Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1805267115.
    PubMed     Text format     Abstract available


    June 2018
  3. ALEMAN F, Tzarum N, Kong L, Nagy K, et al
    Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
    Proc Natl Acad Sci U S A. 2018 Jun 28. pii: 1802378115.
    PubMed     Text format     Abstract available


    April 2018
  4. YIN X, Ying D, Lhomme S, Tang Z, et al
    Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection.
    Proc Natl Acad Sci U S A. 2018 Apr 18. pii: 1721345115.
    PubMed     Text format     Abstract available


    December 2017
  5. MANKOWSKI MC, Kinchen VJ, Wasilewski LN, Flyak AI, et al
    Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1718441115.
    PubMed     Text format     Abstract available



  6. Correction for Giang et al., Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1720228115.
    PubMed     Text format    


    November 2017
  7. HIRANO J, Okamoto T, Sugiyama Y, Suzuki T, et al
    Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.
    Proc Natl Acad Sci U S A. 2017 Nov 29. pii: 1712484114.
    PubMed     Text format     Abstract available


    June 2017
  8. CAO D, Cao QM, Subramaniam S, Yugo DM, et al
    Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.
    Proc Natl Acad Sci U S A. 2017 Jun 19. pii: 201705446.
    PubMed     Text format     Abstract available


  9. KIRKEGAARD K
    Unconventional secretion of hepatitis A virus.
    Proc Natl Acad Sci U S A. 2017 Jun 12. pii: 201707142.
    PubMed     Text format    



  10. Correction for Ding et al., Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles.
    Proc Natl Acad Sci U S A. 2017 Jun 5. pii: 201708260.
    PubMed     Text format    


    May 2017
  11. PADMANABHAN P, Dixit NM
    Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201704531.
    PubMed     Text format    


  12. OHASHI H, Koizumi Y, Fukano K, Wakita T, et al
    Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201705234.
    PubMed     Text format    


  13. MCKNIGHT KL, Xie L, Gonzalez-Lopez O, Rivera-Serrano EE, et al
    Protein composition of the hepatitis A virus quasi-envelope.
    Proc Natl Acad Sci U S A. 2017 May 10. pii: 201619519.
    PubMed     Text format     Abstract available


    April 2017
  14. HANSEN MD, Johnsen IB, Stiberg KA, Sherstova T, et al
    Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M.
    Proc Natl Acad Sci U S A. 2017 Apr 7. pii: 201616683.
    PubMed     Text format     Abstract available


    March 2017

  15. Correction for Koizumi et al., Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.
    Proc Natl Acad Sci U S A. 2017 Mar 6. pii: 201702625.
    PubMed     Text format    


    February 2017
  16. KOIZUMI Y, Ohashi H, Nakajima S, Tanaka Y, et al
    Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.
    Proc Natl Acad Sci U S A. 2017 Feb 7. pii: 201610197.
    PubMed     Text format     Abstract available


  17. QI H, Chu V, Wu NC, Chen Z, et al
    Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
    Proc Natl Acad Sci U S A. 2017 Feb 3. pii: 201614623.
    PubMed     Text format     Abstract available


    January 2017
  18. DING Q, Heller B, Capuccino JM, Song B, et al
    Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles.
    Proc Natl Acad Sci U S A. 2017 Jan 17. pii: 201614955.
    PubMed     Text format     Abstract available


  19. WANG X, Zhu L, Dang M, Hu Z, et al
    Potent neutralization of hepatitis A virus reveals a receptor mimic mechanism and the receptor recognition site.
    Proc Natl Acad Sci U S A. 2017 Jan 10. pii: 201616502.
    PubMed     Text format     Abstract available


    December 2016
  20. LIU WL, Yang HC, Hsu CS, Wang CC, et al
    Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.
    Proc Natl Acad Sci U S A. 2016 Dec 6. pii: 201618517.
    PubMed     Text format     Abstract available


    October 2016
  21. PIERCE BG, Keck ZY, Lau P, Fauvelle C, et al
    Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine design.
    Proc Natl Acad Sci U S A. 2016 Oct 26. pii: 201614942.
    PubMed     Text format     Abstract available


  22. KONG L, Lee DE, Kadam RU, Liu T, et al
    Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201609780.
    PubMed     Text format     Abstract available


  23. WOZNIAK AL, Long A, Jones-Jamtgaard KN, Weinman SA, et al
    Hepatitis C virus promotes virion secretion through cleavage of the Rab7 adaptor protein RILP.
    Proc Natl Acad Sci U S A. 2016 Oct 17. pii: 201607277.
    PubMed     Text format     Abstract available


    September 2016
  24. HONEGGER JR, Tedesco D, Kohout JA, Prasad MR, et al
    Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery.
    Proc Natl Acad Sci U S A. 2016 Sep 6. pii: 201602337.
    PubMed     Text format     Abstract available


    June 2016
  25. COLPITTS CC, Lupberger J, Baumert TF
    Multifaceted role of E-cadherin in hepatitis C virus infection and pathogenesis.
    Proc Natl Acad Sci U S A. 2016 Jun 24. pii: 201607732.
    PubMed     Text format    


  26. LI Q, Sodroski C, Lowey B, Schweitzer CJ, et al
    Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
    Proc Natl Acad Sci U S A. 2016 Jun 13. pii: 201602701.
    PubMed     Text format     Abstract available


    February 2016
  27. LUSSIGNOL M, Kopp M, Molloy K, Vizcay-Barrena G, et al
    Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis.
    Proc Natl Acad Sci U S A. 2016 Feb 16. pii: 201518934.
    PubMed     Text format     Abstract available


  28. JIANG T, Liu M, Wu J, Shi Y, et al
    Structural and biochemical analysis of Bcl-2 interaction with the hepatitis B virus protein HBx.
    Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201525616.
    PubMed     Text format     Abstract available


    January 2016
  29. HAROUAKA D, Engle RE, Wollenberg K, Diaz G, et al
    Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue.
    Proc Natl Acad Sci U S A. 2016 Jan 19. pii: 201516879.
    PubMed     Text format     Abstract available


    December 2015
  30. UJINO S, Nishitsuji H, Hishiki T, Sugiyama K, et al
    Hepatitis C virus utilizes VLDLR as a novel entry pathway.
    Proc Natl Acad Sci U S A. 2015 Dec 23. pii: 201506524.
    PubMed     Text format     Abstract available


    November 2015
  31. KLUMPP K, Lam AM, Lukacs C, Vogel R, et al
    High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein.
    Proc Natl Acad Sci U S A. 2015 Nov 23. pii: 201513803.
    PubMed     Text format     Abstract available


  32. ROWLANDS DJ
    Human hepatitis A virus is united with a host of relations.
    Proc Natl Acad Sci U S A. 2015 Nov 18. pii: 201520121.
    PubMed     Text format    


  33. DREXLER JF, Corman VM, Lukashev AN, van den Brand JM, et al
    Evolutionary origins of hepatitis A virus in small mammals.
    Proc Natl Acad Sci U S A. 2015 Nov 2. pii: 201516992.
    PubMed     Text format     Abstract available


    September 2015
  34. LU Y, Chan W, Ko BY, VanLang CC, et al
    Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
    Proc Natl Acad Sci U S A. 2015 Sep 21. pii: 201510533.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: